Skip to content
Screener

Integra LifeSciences IART Q1 2026 earnings

Reported May 5, 2026 · Before market open

Revenue$391.9MBeat by $10.1M
EPS$0.54Beat by $0.13
Revenue estimate$381.8M
EPS estimate$0.41

Next report

Oct 29, 2026 (in a month)
Revenue estimate$416.3M
EPS estimate$0.56

Financials

Q1 2026

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$734.17M-56.8%
Enterprise value$2.47B-26.7%
P/S0.4×-0.6×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%—

Returns & leverage

See full
Return on equity-38.6%—
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Segments

By product

See full
Neurosurgery$198.2M+3.8%
Wound Reconstruction$79.6M+6.5%
Instruments$47.2M-7.3%
ENT$37.7M-2.8%
Private Label$29.1M+7.1%

By geography

See full
Asia Pacific$45.2M+0.2%
Europe$40.0M+13.1%
Rest of World$17.4M-13.2%

By segment

See full
Specialty Surgery$283.1M—
Tissue Reconstruction$108.8M—

FAQ

When did Integra LifeSciences report Q1 2026 earnings?
Integra LifeSciences (IART) reported Q1 2026 earnings on May 5, 2026 before market open.
What were Integra LifeSciences's Q1 2026 revenue and EPS?
Integra LifeSciences reported revenue of $391.9M and eps of $0.54 for Q1 2026.
Did Integra LifeSciences beat estimates in Q1 2026?
Revenue beat the consensus estimate of $381.8M by $10.1M. EPS beat the consensus estimate of $0.41 by $0.13.
How did Integra LifeSciences's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 2.4% from $382.7M a year earlier and eps grew 31.7% from $0.41.
Where can I find Integra LifeSciences's Q1 2026 SEC filings?
You can read the 8-K earnings release (0000917520-26-000033) and the 10-Q periodic report (0000917520-26-000041) directly on SEC EDGAR. The filing index links above go to sec.gov.